4E Therapeutics is classified as operating in the N/A industry, NAICS Code .
Investor Activity
4E Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
November 12, 2021
23
95%
$2 MM
Complete list of funding rounds and total amounts in the Company Report
Other Companies at 3800 N Lamar Blvd Ste 200, Austin TX
Future Competition: 4E Therapeutics's Fastest Growing Competitors
These companies are in the same general field as 4E Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.